The Front Room — a clinical regulatory commons
RSS
← Back to The Docket
SEP 16 2026
UPCOMING · 105 DAYS TO PDUFA

Telix Pharmaceuticals Limited Pixclara (TLX101-Px) $TLX

for brain cancer imaging

NDA

Accepted APR 10 2026.

About

Glioblastoma is an aggressive brain tumor that grows rapidly and often resists treatment, leading to poor survival rates. Pixclara is a diagnostic imaging agent that binds to specific markers on glioblastoma cells, making them visible under medical scans. This targeting could help doctors more accurately map tumors for surgical removal or radiation planning.